Two-fraction HDR Monotherapy for Localized Prostate Cancer
Two-fraction HDR Monotherapy for Localized Prostate Cancer
Recruiting · NCT05665738 · Registry updated 2026-09-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Two-fraction HDR Monotherapy for Localized Prostate Cancer | prostate adenocarcinoma | Recruiting | Not applicable | 2026-09-17 | NCT05665738 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of California, San Francisco | 637 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of California, San Francisco | San Francisco | United States | 294 |